Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Biotin-16-UTP: Biotin-Labeled RNA Synthesis for Detection...

    2026-01-22

    Biotin-16-UTP: Biotin-Labeled RNA Synthesis for Detection and Purification

    Executive Summary: Biotin-16-UTP (C32H52N7O19P3S, MW 963.8) is a chemically modified uridine triphosphate featuring a biotin moiety covalently linked via a 16-atom spacer, enabling site-specific incorporation into RNA during in vitro transcription (APExBIO product page). The biotin tag allows subsequent affinity purification or detection using streptavidin or anti-biotin reagents (Guo et al., 2022). This reagent is validated for applications such as RNA-protein interaction mapping, RNA localization assays, and nucleic acid purification. Purity is ≥90% (AX-HPLC), and the reagent must be stored at -20°C or lower. Biotin-16-UTP is central to workflows requiring sensitive, specific, and non-radioactive RNA labeling (internal review).

    Biological Rationale

    RNA-protein interactions underlie fundamental gene regulatory mechanisms, including translation initiation, splicing, and decay (Guo et al., 2022). In vitro transcription using modified nucleotides allows researchers to generate labeled RNA for downstream studies. Biotin-16-UTP, a uridine triphosphate analog, is designed for enzymatic incorporation by T7, SP6, or T3 RNA polymerases, enabling site-specific biotinylation of transcripts. The strong, nearly irreversible binding between biotin and streptavidin (Kd ≈ 10-14 M) facilitates efficient capture and detection of biotinylated RNA, making this system ideal for affinity purification or imaging (APExBIO). Biotin labeling also avoids radioactive hazards and provides compatibility with multiplex detection schemes. Long non-coding RNAs (lncRNAs) and their protein partners, as studied in hepatocellular carcinoma models, require precise mapping tools like biotin-labeled probes (Guo et al., 2022).

    Mechanism of Action of Biotin-16-UTP

    Biotin-16-UTP is structurally analogous to natural UTP but contains a long-chain biotin moiety at the 5-position of the uracil base. During in vitro transcription, RNA polymerases incorporate Biotin-16-UTP in place of UTP, resulting in biotin-modified RNA transcripts. The 16-atom linker minimizes steric hindrance, preserving RNA polymerase efficiency and downstream hybridization fidelity. Following transcription, biotinylated RNA can be detected with streptavidin-conjugated fluorophores or affinity-purified with streptavidin-coated beads. This labeling enables downstream applications such as RNA-protein pulldown, northern blotting, and immobilization for kinetic assays. Biotin-16-UTP is supplied in solution and should be handled under RNase-free conditions to avoid degradation.

    Evidence & Benchmarks

    • Biotin-16-UTP is efficiently incorporated by T7 RNA polymerase at up to 30% of total UTP without loss of yield or integrity (internal validation).
    • Labeled RNA remains compatible with high-affinity streptavidin binding, enabling recovery yields >90% in affinity purification protocols (case study).
    • Biotin-16-UTP-labeled probes are routinely used for RNA localization in situ hybridization, outperforming fluorescently labeled nucleotides in terms of photostability and multiplexing (review).
    • In lncRNA-protein interaction studies, biotinylated RNA generated with Biotin-16-UTP enabled pulldown of EIF4G1, validating functional mapping in hepatocellular carcinoma models (Guo et al., 2022).
    • RNA synthesized with Biotin-16-UTP is stable for >6 months at -20°C, assuming proper storage in RNase-free, buffered solution (APExBIO).

    Applications, Limits & Misconceptions

    Biotin-16-UTP is widely used for:

    • RNA-protein interaction studies (e.g., pulldown/CLIP assays).
    • RNA detection and purification (e.g., northern blot, affinity chromatography).
    • RNA localization assays (e.g., in situ hybridization).
    • Metatranscriptomic studies requiring non-radioactive labeling.

    This article extends the discussion in "Biotin-16-UTP: Transforming RNA Detection for Environment..." by providing detailed mechanistic rationale and protocol limitations relevant to mammalian transcriptomics. See also "Biotin-16-UTP: Biotin-Labeled RNA Synthesis for Detection...", which focuses on metatranscriptomic workflows; this article addresses cancer and lncRNA contexts. For a deep dive into mechanism, compare "Biotin-16-UTP: Advanced RNA Labeling for Mechanistic lncR..."—this present review adds practical troubleshooting and benchmark data.

    Common Pitfalls or Misconceptions

    • Biotin-16-UTP is not compatible with in vivo RNA labeling; it is designed for in vitro transcription only.
    • High substitution rates (>50% Biotin-16-UTP:UTP) may reduce RNA yield or affect secondary structure.
    • RNA synthesized with Biotin-16-UTP cannot be directly used for translation assays requiring native ribosomal function.
    • Biotin-16-UTP-labeled RNA is not suitable for applications requiring uniform charge or mass, such as some NMR or mass spec protocols.
    • Streptavidin pulldown is susceptible to interference by free biotin or excess detergent in buffers.

    Workflow Integration & Parameters

    Typical in vitro transcription reactions incorporate Biotin-16-UTP at 10–30% of total UTP, using T7, SP6, or T3 RNA polymerase in RNase-free buffer (e.g., 40 mM Tris-HCl, 6 mM MgCl2, pH 7.5, at 37°C for 1–2 hours). The B8154 kit from APExBIO offers high-purity reagent and is shipped on dry ice for maximum stability. Post-reaction, DNase treatment and ethanol precipitation are recommended. The resulting biotinylated RNA can be detected using streptavidin-HRP or -fluorophore conjugates (dilution per manufacturer). For RNA-protein pulldown, use streptavidin magnetic beads (10–50 μL bead slurry per 1–5 μg RNA), incubate at 4°C for 30–60 minutes, and wash with low-salt buffer (e.g., 1× PBS, 0.1% Triton X-100). For lncRNA-protein mapping, validated protocols demonstrate successful recovery of interacting proteins such as EIF4G1 from hepatocellular carcinoma cell lysates (Guo et al., 2022).

    Conclusion & Outlook

    Biotin-16-UTP is a validated, high-purity modified nucleotide that streamlines RNA labeling for detection, purification, and interaction studies. Its robust performance in lncRNA research and cancer models, combined with safety and workflow compatibility, make it a preferred tool for modern molecular biology. Ongoing optimization of labeling conditions and integration with multi-omics platforms will further expand its utility in transcriptomics and RNA-centric therapeutics. For detailed protocols and application notes, refer to the APExBIO Biotin-16-UTP product page.